Cure My Disease

Don't miss your cure!

 Log in / Sign up

New registry tracks ESD success for GI lesions in 1,000 patients

NCT ID NCT05468008

Recruiting now Knowledge-focused Sponsor: AdventHealth Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This registry study is tracking 1,000 adults who are scheduled to undergo endoscopic submucosal dissection (ESD), a procedure that removes deep tumors from the digestive tract without major surgery. Researchers want to see how well ESD works in a Western population, measuring things like complete removal rates. All patients receive standard medical care, and no experimental treatments are given.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could confirm that ESD is a safe and effective outpatient procedure for removing deep GI tumors in Western patients, potentially improving treatment guidelines.
What could go wrong
This is an observational registry, not a controlled trial, so results may not prove ESD is better than other treatments. Outcomes depend on standard care, and the study is still recruiting.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BARRETT ESOPHAGUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Barrett esophagus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BARRETT ESOPHAGUS ESOPHAGEAL LESION GASTROINTESTINAL LESIONS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AdventHealth Orlando

    RECRUITING

    Orlando, Florida, 32803, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.